USSTOCK.TODAY
Market Closed
Log in Sign up

Acadia Pharmaceuticals Beats Q3 Earnings and Revenue Estimates

Associated Press · ·by G4L

ACAD
ACAD Acadia Pharmaceuticals Inc
$16.50 -22.28%
View chart & analysis →
  1. 1Acadia Pharmaceuticals Inc. reported Q3 earnings of $53.5 million.
  2. 2Acadia Pharmaceuticals Inc. achieved revenue of $342.3 million.
  3. 3Acadia provided an annual revenue guidance range of $1.26 billion to $1.3 billion.

So what's the key point?

Acadia Pharmaceuticals Inc. earned more money in the third quarter than experts expected. The company also stated that its annual revenue will be between $1.26 billion and $1.3 billion.

Source Associated Press · View original ↗

Related 3-line summaries

Arcadia Pharmaceuticals Reports Q3 Revenue Growth and Raises DAYBUE Guidance The Motley Fool +1 · 2d agoViavi Solutions beats market expectations for fiscal Q1 revenue and net income Associated Press +1 · 4d agoCisco's AI super cycle faces first test with declining margins and stock price Earnings Whispers +1 · 4d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news